Medical News

RSS

Rockwell Medical announces design of Phase III development program for Soluble Ferric Pyrophosphate

Rockwell Medical, a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease (ESRD), chronic kidney disease (CKD), and iron-deficiency anemia, announced today the design of its Phase III development program for Soluble Ferric Pyrophosphate (SFP) as a continuous iron replacement therapeutic.

20 Oct 2010

BREAKYL drug receives European approval

BioDelivery Sciences International, Inc. and Meda today announced approval of BEMA Fentanyl in Europe via the Decentralized Procedure, with Germany acting as Reference Member State.

20 Oct 2010

Genoptix ranked #41 on Deloitte's Technology Fast 500

Genoptix, Inc., a specialized laboratory services provider, today announced that it ranked number 41 on Technology Fast 500™, Deloitte's ranking of 500 of the fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. Rankings are based on percentage of fiscal year revenue growth during the five year period from 2005–2009. Genoptix grew 3,451 percent during this period.

20 Oct 2010

Aradigm reports positive data from DRCFI, ARD-3150 Phase 2b bronchiectasis study

Aradigm Corporation today announced positive top line data from its recently concluded 6-month Phase 2b study (ORBIT-2) with Aradigm's once-daily dual release ciprofloxacin for inhalation (DRCFI, ARD-3150) in patients with non-cystic fibrosis bronchiectasis.

20 Oct 2010

SXC's informedRx PBM unit receives three-year contract

SXC Health Solutions Corp. a leading provider of pharmacy benefit management (PBM) products and services, today announced that its informedRx PBM unit has been awarded a three-year contract valued at approximately $240 million per year with a large Health Plan based on the U.S. east coast.

20 Oct 2010

EarlySense closes additional US$7 million D financing round

EarlySense, developer of the EverOn patient supervision system for hospital and post acute care, announced today that the company has closed an additional US$7 million D financing round led by JK & B.

20 Oct 2010

NMT releases new device for treatment of post-operative nausea

Neurowave Medical Technologies™ today announced the release of an innovative new device for the treatment of post-operative nausea, medically referred to as emesis. Reletex™ is a novel transdermal neuromodulation device that is non-invasive and drug-free, and has been demonstrated to alleviate nausea when used as an adjunct to anti-emetics.

20 Oct 2010

Pfizer enters partnership with Teuto to develop, commercialize generic medicines

Pfizer Inc. announced today that it is entering into a partnership with Laboratorio Teuto Brasileiro S.A., a leading company in the Brazilian generics industry, to develop and commercialize generic medicines.

20 Oct 2010

Quest Diagnostics third quarter revenues decrease 1.7% to $1.9 billion

Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, announced that for the third quarter ended September 30, 2010, income from continuing operations increased to $198 million, or $1.13 per diluted share, from $192 million, or $1.02 per diluted share, for the third quarter of 2009.

From Quest Diagnostics 20 Oct 2010

St. Jude Medical third quarter net sales increase 7% to $1.240 billion

St. Jude Medical, Inc. today reported sales and net earnings for the third quarter ended October 2, 2010.

20 Oct 2010

First Edition: October 20, 2010

Kaiser Health News staff writer Julie Appleby reports One of the nation's largest health insurers said today it is testing a new way to pay for some cancer treatments, aiming to identify the best medicines and limit profits doctors make by dispensing in-office chemotherapy drugs.

20 Oct 2010

European Commission grants Ipsen's OBI-1 orphan drug status for treatment of hemophilia

Ipsen announced today that the European Commission has granted orphan drug status for OBI-1 for the treatment of hemophilia. Expected to enter pivotal clinical trials before the end of this year, OBI-1 is designed to treat individuals with hemophilia who have developed inhibitory antibodies (inhibitors) against human Factor VIII (hFVIII).

20 Oct 2010

New model for rural clinics in underserved areas

The University of Maryland Dental School Clinic, Perryville is a new model for rural clinics in underserved areas across the country, says Christian S. Stohler, DMD, DrMedDent, dean of the Dental School in Baltimore.

20 Oct 2010

New book on Alzheimer's epidemic

Providing meaningful roles in society, involving children, and embracing a love-based approach are how America can successfully cope with the soaring numbers of people with Alzheimer's, Parkinson's and other memory-impairing diseases. That's the view of Alzheimer's futurists Loren Shook and Steve Winner, who say the nation must elevate care for those with the disease alongside the ongoing efforts to develop prevention and cure measures.

20 Oct 2010

New solutions to make protein-deficient Indian schoolchildren eat soy products

University of Illinois scientists think they have solved an interesting problem: how to get protein-deficient Indian schoolchildren to consume soy, an inexpensive and complete vegetable protein. What's more, they've joined forces with an Indian foundation that can get the high-protein soy snack they've developed into the hands of 1.2 million hungry kids who need it.

20 Oct 2010

Trained service dogs can help children with Autism Syndrome Disorders

Dogs may not only be man's best friend, they may also have a special role in the lives of children with special needs. According to a new Universit- de Montreal study, specifically trained service dogs can help reduce the anxiety and enhance the socialization skills of children with Autism Syndrome Disorders (ASDs).

20 Oct 2010

LANL's researcher to implement first human trial of mosaic HIV vaccine candidate

Los Alamos National Laboratory researcher Bette Korber is part of an international team of investigators working to design and implement the first human trial of a mosaic HIV vaccine candidate. The vaccine represents a novel strategy for fighting the virus that causes AIDS by attempting to address one of the most daunting challenges in HIV vaccine design: the virus's extensive genetic diversity.

20 Oct 2010

ACS CAN asks federal and state candidates to state positions on cancer issues

The American Cancer Society Cancer Action Network (ACS CAN) is asking federal and state candidates to go on the record with their positions on cancer issues. ACS CAN, the nonpartisan advocacy affiliate of the American Cancer Society, has reached out to more than 500 candidates across the country in a nationwide effort to educate voters about laws and policies that help people fight cancer.

20 Oct 2010

Elsevier / MC Strategies partners with AORN to develop latest module for Perioperative Collection

Elsevier / MC Strategies a pioneer in providing e-learning solutions to more than 1,300 healthcare organizations, has partnered with the Association of periOperative Registered Nurses (AORN) to develop the latest module for Mosby's Nursing Skills Perioperative Collection, the only perioperative-specific set of nursing skills approved by AORN to be consistent with the Standards and Recommended Practices.

20 Oct 2010

Euroscience deeply concerned over governments' proposed cuts in research investment

Across the European Union and the wider Europe, governments are engaged in cutting public expenditure and we are entering an unprecedented period of austerity. Thus, public support for research is now at risk in a manner not seen before and just at the time when Europe faces new challenges from the rising new economies, especially in Asia, and when threats to our quality of life from climate change, demographic change and energy, food and resource availability and sustainability are becoming evermore threatening and urgent.

20 Oct 2010

Medical News

Rockwell Medical announces design of Phase III development program for Soluble Ferric Pyrophosphate

BREAKYL drug receives European approval

Genoptix ranked #41 on Deloitte's Technology Fast 500

Aradigm reports positive data from DRCFI, ARD-3150 Phase 2b bronchiectasis study

SXC's informedRx PBM unit receives three-year contract

EarlySense closes additional US$7 million D financing round

NMT releases new device for treatment of post-operative nausea

Pfizer enters partnership with Teuto to develop, commercialize generic medicines

Quest Diagnostics third quarter revenues decrease 1.7% to $1.9 billion

St. Jude Medical third quarter net sales increase 7% to $1.240 billion

First Edition: October 20, 2010

European Commission grants Ipsen's OBI-1 orphan drug status for treatment of hemophilia

New model for rural clinics in underserved areas

New book on Alzheimer's epidemic

New solutions to make protein-deficient Indian schoolchildren eat soy products

Trained service dogs can help children with Autism Syndrome Disorders

LANL's researcher to implement first human trial of mosaic HIV vaccine candidate

ACS CAN asks federal and state candidates to state positions on cancer issues

Elsevier / MC Strategies partners with AORN to develop latest module for Perioperative Collection

Euroscience deeply concerned over governments' proposed cuts in research investment

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News